Nurix Therapeutics Stock Predictions

The Future of Housing Is Being Built Now

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Sell

NRIX
Nurix Therapeutics

Last Price:

$9.72

Seasonality Move:

29.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Portfolio's Boring. This Company Isn't And It's Early

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio

Nurix Therapeutics Stock Forecast

Over the next 52 weeks, Nurix Therapeutics has on average historically fallen by 8.8% based on the past 4 years of stock performance.
Nurix Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Is Nurix Therapeutics Stock Undervalued?

The current Nurix Therapeutics [NRIX] share price is $9.72. The Score for NRIX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
NRIX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Nurix Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Nurix Therapeutics has on average historically fallen by 8.8% based on the past 4 years of stock performance.

Nurix Therapeutics Stock Rating

Sell

Nurix Therapeutics (NRIX) is a Sell

Is Nurix Therapeutics overpriced?

Nurix Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Nurix Therapeutics Stock Price History

Is NRIX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRIX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

nurixtx.com

52-Week Data

52-Week High:

29.56

52-Week Low:

8.18

Prediction Charts

Market Cap:

741M

Price in USD:

9.72

Volume:

401.5K

Beta:

2.24

Technical Analysis

SMA50:

10.91

SMA100:

14.38

SMA200:

18.82

52-Wk Change:

-35.93%

Stock Predictions

Is Nurix Therapeutics stock public?

Yes, Nurix Therapeutics is a publicly traded company.
What is the Nurix Therapeutics stock quote today?

The Nurix Therapeutics stock price is 9.72 USD today.
How to buy Nurix Therapeutics stock online?

You can buy Nurix Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-6	10.82	9.65	10.86	9.64
May-7	9.70	9.30	9.71	9.20
May-8	9.52	9.64	9.88	9.02
May-9	9.65	9.50	10.03	9.50
May-12	9.94	10.18	10.38	9.82
May-13	10.25	9.73	10.26	9.70
May-14	9.78	9.58	9.89	9.34
May-15	9.64	9.46	9.67	9.32
May-16	9.46	9.56	9.69	9.33
May-19	9.34	9.51	9.67	9.25
May-20	9.49	10.14	10.14	9.30
May-21	10.03	9.78	10.03	9.49
May-22	9.68	9.99	10.10	9.51
May-23	9.74	9.72	9.86	9.55

Nurix Therapeutics Earnings

Nurix Therapeutics Earnings Report: Per Share Nurix Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Nurix Therapeutics Forecast Revenue Growth

Nurix Therapeutics Stock Analysis: Historical quarterly revenues per share for Nurix Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.23 per share.

* Nurix Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.